Press Release FeedGet the RSS feed
Menu

GlobeNewswire

Geron Plans to Announce Third Quarter 2026 Financial Results on November 4, 2026

GlobeNewswire

October 21, 2026 08:00 ET  | Source: Geron Corporation

FOSTER CITY, Calif., Oct. 21, 2026 -- Geron Corporation (Nasdaq: GERN), a hematology-focused biopharmaceutical company pursuing more meaningful moments for people living with blood cancer, today announced that it will release its third quarter 2026 financial results and business highlights before the market opens on Wednesday, November 4, 2026, via press release, which will be available on the Investors section of the Company’s website. Geron will host a conference call and webcast at 8:00 a.m. Eastern Time.

A live and archived audio webcast of the conference call will be available through the Investors section of the Company’s website at www.geron.com.

About Geron
Geron is a hematology-focused biopharmaceutical company pursuing more meaningful moments for people living with blood cancer. Because patients cannot wait, we approach our work with urgency, bringing together deep expertise in telomerase biology with patient perspectives and insights from clinical research and real-world care. Our medicine, RYTELO® (imetelstat), is approved in the United States and European Union for certain patients with lower-risk myelodysplastic syndromes (LR-MDS). We are building on our foundation in telomerase inhibition by studying imetelstat in myelofibrosis, including a pivotal Phase 3 clinical trial in patients with JAK-inhibitor relapsed/refractory disease, as well as other hematologic malignancies. Geron is a commercial-stage company with offices in Parsippany, New Jersey and Foster City, California. To learn more, visit www.geron.com or follow us on LinkedIn.

Investors and Media
Dawn Schottlandt
Senior Vice President, Investor Relations and Corporate Affairs
[email protected]

  1. Cyabra Named a Sample Vendor in 10 Gartner® Hype Cycle™ ReportsAs digital threats grow more sophisticated, Cyabra continues to help governments and enterprises detect coordinated manipulation and protect digital trust.
  2. FinanceTron Inc. Super Representative Node Rises to Number 1 Rank on TRON NetworkTron Inc. (Nasdaq: TRON), the largest publicly traded holder of TRON (TRX) tokens, today provided an update on its TRON network integration initiatives.
  3. CryptoAlpha Modus Highlights Bitcoin Holdings with Value Exceeding $250 Million*, Potential $225 Million in Additional Cash Proceeds, ARIA Expansion Targeting Over 20,000 Retail Locations and Significant Federal Patent Litigation MilestonesAlpha Modus highlights $250M+ in Bitcoin, $225M in potential warrant proceeds, ARIA's 20,000+ retail pipeline and federal patent litigation progress.
  4. FinanceHIIHII Increases Quarterly Dividend to $1.41 per ShareCompanies: Huntington Ingalls IndustriesHII (NYSE: HII) announced today that its Board of Directors has declared a quarterly cash dividend of $1.41 per share, a $0.03 increase over the $1.38 per share dividend paid in each of the prior four quarters. The $1.41 per share dividend will be payable on Dec. 11, 2026, to shareholders of record as of the close of business on Nov. 27, 2026.
  5. Biotech & pharmaIMUNON Announces Strategic Sale of ThermoDox®Agreement with VoxelDox Therapeutics, Inc. Creates a Clear Path to Future Value, Subject to Achievement of Development Milestones in the Planned Phase 1 Glioblastoma Trial
  6. CryptoRunItUp Creators Earn More Than $63,000 as Trading Passes $2.9M Across Five ChainsRunItUp, a multichain token launchpad live on Robinhood Chain, BNB Chain, Ethereum, Base and Arc, has passed $2.9 million in trading volume across nearly 30,000 trades. According to platform data as of Oct. 19, 2026, 404 tokens have launched across the five mainnets, 115 creators earn trading fees, and creators have been paid more than $63,000 in total.